Nuveen Asset Management, LLC Applied Genetic Technologies Corp Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.62 - $5.23 $3.14 Million - $4.54 Million	-867,592 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.94 - $8.19 $3.01 Million - $6.25 Million	762,841 Added 728.24%	867,592 $4.4 Million
Q4 2020 Feb 16, 2021	BUY	$3.99 - $5.7 $15,561 - $22,230	3,900 Added 3.87%	104,751 $428,000
Q3 2020 Nov 16, 2020	SELL	$4.38 - $6.43 $43 - $64	-10 Reduced 0.01%	100,851 $490,000
Q2 2020 Aug 14, 2020	BUY	$3.0 - $6.9 $302,583 - $695,940	100,861 New	100,861 $559,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.